Alexandria Real Estate Equities
53
20M
40
1.77
1
0.23
14
- Stages of investment
- Areas of investment
Summary
Alexandria Real Estate Equities appeared to be the Corporate Investor, which was created in 1994. The company was established in North America in United States. The main department of described Corporate Investor is located in the Pasadena.
The high activity for fund was in 2017. Despite it in 2019 the fund had an activity. The usual things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this Corporate Investor is 18 percentage points less often commits exit comparing to other organizations. The increased amount of exits for fund were in 2014. The typical startup value when the investment from Alexandria Real Estate Equities is 10-50 millions dollars. Comparing to the other companies, this Alexandria Real Estate Equities performs on 7 percentage points less the average number of lead investments. The fund is constantly included in less than 2 deals per year.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the various public portfolio startups of the fund, we may underline KSQ Therapeutics, Cydan, OncoResponse Among the most successful fund investment fields, there are Pharmaceutical, Life Science. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.
The current fund was established by Joel Marcus. Besides them, we counted 1 critical employee of this fund in our database.
The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Alexandria Real Estate Equities, startups are often financed by Polaris Partners, MPM Capital, Amgen Ventures. The meaningful sponsors for the fund in investment in the same round are Versant Ventures, MPM Capital, Polaris Partners. In the next rounds fund is usually obtained by ARCH Venture Partners, Polaris Partners, Amgen Ventures.
Investments analytics
Analytics
- Total investments
- 53
- Lead investments
- 1
- Exits
- 14
- Rounds per year
- 1.77
- Follow on index
- 0.23
- Investments by industry
- Biotechnology (40)
- Health Care (21)
- Therapeutics (17)
- Medical (15)
- Pharmaceutical (9) Show 32 more
- Investments by region
-
- United States (52)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Avg. valuation at time of investment
- 29M
- Group Appearance index
- 0.98
- Avg. company exit year
- 10
- Avg. multiplicator
- 1.94
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Hypnion | 19 Dec 2005 | Biotechnology, Health Diagnostics, Medical, Therapeutics | Early Stage Venture | 20M | United States, Massachusetts |
| TFC Therapeutics | 17 Aug 2023 | Biotechnology, Medical, Biopharma | Seed | United States, New York, Nyack | |
| Wefunder | 07 Oct 2014 | Financial Software, Other Financial Services, Brokerage, Financial Services, Finance, Funding Platform | Seed | 0 | United States, California, San Francisco |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.